PSMD10P3

Across TCGA pan-cancer cohorts, PSMD10P3 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated PSMD10P3 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher PSMD10P3 RNA is associated with better overall survival. In most high-consensus cancer types, elevated PSMD10P3 expression acts as an unfavorable survival marker, although some lineages such as BLCA and BRCA show a favorable association.

BLCA, THCA, and UVM are the cancer types where PSMD10P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	II,III,IV	0.637	0.398	.002	108	view →
THCA	DFS	Tertile	III,IV	0.767	0.921	.003	57	view →
UVM	DFS	Tertile	All	0.295	0.768	.015	36	view →
BRCA	DFS	Tertile	All	0.737	0.483	.005	36	view →
KIRC	DFS	Tertile	IV	0.321	0.568	.010	24	view →
LUSC	OS	Quartile	II,III,IV	0.732	0.589	.025	13	view →
CHOL	OS	Tertile	All	0.168	0.624	.019	9	view →
READ	OS	Tertile	IV	0.644	0.899	.019	9	view →
HNSC	DFS	Tertile	II,III,IV	0.437	0.328	.047	6	view →
STAD	OS	Tertile	IV	0.744	0.324	.031	3	view →
DLBC	DFS	Median	IV	1.000	0.415	.035	2	view →
ESCA	DFS	Median	II,III,IV	0.551	0.410	.038	1	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

PSMD10P3–BLCA (OS)

Open the BLCA breakdown →